Brain Tumor

  •  NCCTG N107C– A Phase III Trial of Post-Surgical Sterotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease
  • RTOG 1205– Randomized Phase II Trial of Concurrent Bevacizumab and Re-Irradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
  • Alliance N1174– Randomized Phase I Comparative Trial of TRC105 Plus Bevacizumab Versus Bevacizumab in Bevacizumab-Naive Patients with Recurrent Glioblastoma Multiforme
  • NCCTG N0577– A Phase III Intergroup Study of Radiotherapy versus Temozolomide alone versus Radiotherapy with Concomitant and Adjuvant Temozolomide for Patients with 1p/19q Codeleted Anaplastic Glioma (Not credentialed-temporarily closed)
  • RTOG 0631– A Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis
  • NRG-BN001– Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation with Concomitant and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma
  • Alliance A071102– A Phase II/III Randomized Trial of Veliparib or Placebo in Combination with Adjuvant Temozolomide in Newly Diagnosed Glioblastoma with MGMT Promoter Hypermethylation
  • Alliance A071401– A Phase II Trial of SMO/AKT/NF2 Inhibitors in Progressive Menigiomas with SMO/AKT/NF2 Mutations
  • NRG-CC001– A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy with or without Hippocampal Avoidance in Patients with Brain Metastatis